1Bissell DM, Roulot D, George J, et al. Transforming growth factor β and liver. Hepatology, 2001,34:859-867.
2Border WA, Noble NA. Transforming growth factor beta in tissue fibrosis. New Engl J Med, 1993,331:1286-1292.
3Nagashio Y, Ueno H, Imamura M, et al. Inhibition of transforming growth factor beta decreases pancreatic fibrosis and protects the pancreas against chronic injury in mice. Lab Invest, 2004,84:1610-1618.
4Gressner AM, Weiskirchen R. The tightrope of therapeutic suppression of active transforming growth factor-β:high enough to fall deeply? J Hepatol, 2003,39:856-859.
5Friedman SL. Molecular regulation of hepatic fibrosis, an intergrated cellular response to tissue injury. J Biol Chem, 2003,275:2247-2250.
6Gressner AM, Weiskirchen R, Breitkopf K, et al. Roles of TGFβ in hepatic fibrosis. Front Biosci, 2002,7:793-807.
7Dooley S, Delvoux B, Lahme B, et al. Modulation of transforming growth factor beta response and signaling during transdifferentiation of rat hepatic stellate cells to myofibroblasts. Hepatology, 2000,31:1094-1106.
8Gressner AM, Gao CF. A cascade mechanism of fat storing cell activation forms the basis of the fibrogenic reaction of the liver. Verh Dtsch Ges Pathol, 1995,79:1-14.
9Poncelet AC, Schnaper HW. Sp1 and Smad proteins cooperate to mediate transforming growth factor-beta 1-induced alpha 2(I) collagen expression in human glomerular mesangial cells. J Biol Chem, 2001, 276: 6983-6992.
10Chadjichristos C, Ghayor C, Herrouin JF, et al. Down-regulation of human type II collagen gene expression by transforming growth factor-beta 1 (TGF-beta 1) in articular chondrocytes involves SP3/SP1 ratio. J Biol Chem, 2002, 277: 43903-43917.
二级参考文献13
1[1]Lawrence DA. Transforming growth factor-β: An overview. Kidney Int, 1995,47: s-19-23.
2[2]Barnard JA, Lyons RM, Moses HM. The cell biology of transforming growth factor β. Biotic Biopsy Acct,1990,1032:79-87.
3[3]Bodes P, Parades V. Transforming growth factor-β: a key-role in liver fibrogenesis. J Hepatol, 1995,22 (Suppl. 2): 37-42.
4[4]Asian RK, Sporran MB. Type beta transforming growth factor in human platelets: release during platelet degranulation and action on vascular smooth muscle cells. J Cell Biol,1986,102:1217-1223.
5[1]Blobe GC, Schiemann WP, Lodish HF. Role of transforming growth factor beta in human disease[J]. N Engl J Med, 2000,342(18): 1350-1358.
6[2]Bachem MG,Meyer D,Melchior R,et al. Activation of rat liver perisinusoidal lipocytes by transforming growth factors derived rom myofibroblast like cells. A potential mechanism of selfperpetuation in liver fibrogenesis[J]. J Clin Invest, 1992, 89(1):19-27.
7[3]Gewaltig J,Mangasser-Stephan K,Gartung C,et al. Association of polymorphisms of the transforming growth factor-β1gene with the rate of progression of HCV-induced liver fibrosis [J]. Clin Chim Acta,2002,316(1-2) :83-94.
8[4]Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitits C. The French METAVIR Cooperative Study Group[J]. Hepatology, 1994,20(1):15-20.
9[5]Bedossa P,Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The French METAVIR Cooperative Study Group[J]. Hepatology,1996,24(2) :289-293.
10[6]Bataller R, North, KE, Brenner DA. Genetic polymorphisms and the progression of liver fibrosis: a critical appraisal[J].Hepatology, 2003,37 (3): 493-503.
2Hui Cao, Jia Xu, Rong Hua, Fang-Bin Meng, Jiang-Feng Qiu and Zhi-Yong Wu Department of Surgery, Renji Hospital, Shanghai Second Medical University, Shanghai 200127, China.Expression of cyclooxygenase in hyperdynamic portal hypertensive rats[J].Hepatobiliary & Pancreatic Diseases International,2006,5(2):252-256. 被引量：8
